219 related articles for article (PubMed ID: 37222047)
21. TLR7 ligand augments GM-CSF-initiated antitumor immunity through activation of plasmacytoid dendritic cells.
Narusawa M; Inoue H; Sakamoto C; Matsumura Y; Takahashi A; Inoue T; Watanabe A; Miyamoto S; Miura Y; Hijikata Y; Tanaka Y; Inoue M; Takayama K; Okazaki T; Hasegawa M; Nakanishi Y; Tani K
Cancer Immunol Res; 2014 Jun; 2(6):568-80. PubMed ID: 24830413
[TBL] [Abstract][Full Text] [Related]
22. Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation.
Avigan D; Wu Z; Gong J; Joyce R; Levine J; Elias A; Richardson P; Milano J; Kennedy L; Anderson K; Kufe D
Clin Cancer Res; 1999 Oct; 5(10):2735-41. PubMed ID: 10537336
[TBL] [Abstract][Full Text] [Related]
23. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
24. Sonodynamical reversion of immunosuppressive microenvironment in prostate cancer via engineered exosomes.
Wang D; Wan Z; Yang Q; Chen J; Liu Y; Lu F; Tang J
Drug Deliv; 2022 Dec; 29(1):702-713. PubMed ID: 35236203
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of tumor recurrence and metastasis
Lu Y; Wu C; Yang Y; Chen X; Ge F; Wang J; Deng J
Biomater Sci; 2022 Mar; 10(5):1352-1363. PubMed ID: 35112690
[TBL] [Abstract][Full Text] [Related]
26. [GM-CSF gene-modified dendritic cell vaccine enhances antitumor immunity in vitro].
He SB; Sun K; Wang L; Li DC; Zhang YY
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):410-4. PubMed ID: 20819479
[TBL] [Abstract][Full Text] [Related]
27. B7-1 and GM-CSF enhance the anti-tumor immune effect of DC-tumor fusion vaccine in the treatment of prostate cancer.
Lian T; Hao X; Li J; Wang H; Li C
Med Oncol; 2020 Nov; 37(11):107. PubMed ID: 33136217
[TBL] [Abstract][Full Text] [Related]
28. Biosynthetic neoantigen displayed on bacteria derived vesicles elicit systemic antitumour immunity.
Meng F; Li L; Zhang Z; Lin Z; Zhang J; Song X; Xue T; Xing C; Liang X; Zhang X
J Extracell Vesicles; 2022 Dec; 11(12):e12289. PubMed ID: 36468941
[TBL] [Abstract][Full Text] [Related]
29. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
Tseng SH; Chen Y; Chang CJ; Tai KF; Lin SM; Hwang LH
Clin Cancer Res; 2005 Feb; 11(4):1639-49. PubMed ID: 15746069
[TBL] [Abstract][Full Text] [Related]
30. Granulocyte-macrophage-colony-stimulating factor and other cytokines: as adjuncts to cancer immunotherapy, stem cell transplantation, and vaccines.
Arellano M; K Waller E
Curr Hematol Rep; 2004 Nov; 3(6):424-31. PubMed ID: 15496276
[TBL] [Abstract][Full Text] [Related]
31. Injectable Hydrogels Coencapsulating Granulocyte-Macrophage Colony-Stimulating Factor and Ovalbumin Nanoparticles to Enhance Antigen Uptake Efficiency.
Sun Z; Liang J; Dong X; Wang C; Kong D; Lv F
ACS Appl Mater Interfaces; 2018 Jun; 10(24):20315-20325. PubMed ID: 29808993
[TBL] [Abstract][Full Text] [Related]
32. Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: implications for a clinically relevant tumor vaccine.
Mahvi DM; Burkholder JK; Turner J; Culp J; Malter JS; Sondel PM; Yang NS
Hum Gene Ther; 1996 Aug; 7(13):1535-43. PubMed ID: 8864754
[TBL] [Abstract][Full Text] [Related]
33. IL-13 can substitute for IL-4 in the generation of dendritic cells for the induction of cytotoxic T lymphocytes and gene therapy.
Alters SE; Gadea JR; Holm B; Lebkowski J; Philip R
J Immunother; 1999 May; 22(3):229-36. PubMed ID: 10335482
[TBL] [Abstract][Full Text] [Related]
34. MCA106 fibrosarcoma cells transduced with granulocyte/macrophage colony-stimulating factor are not superior to the wild-type cells in suppressing the growth of hepatic metastases.
Dong XD; Abdel-Wahab Z; Dematos P; Fong T; Pruitt SK; Seigler HF
J Surg Oncol; 1999 May; 71(1):36-45. PubMed ID: 10362090
[TBL] [Abstract][Full Text] [Related]
35. Hydrogel-delivered GM-CSF overcomes nonresponsiveness to hepatitis B vaccine through the recruitment and activation of dendritic cells.
Chou HY; Lin XZ; Pan WY; Wu PY; Chang CM; Lin TY; Shen HH; Tao MH
J Immunol; 2010 Nov; 185(9):5468-75. PubMed ID: 20889541
[TBL] [Abstract][Full Text] [Related]
36. Albumin fusion with granulocyte-macrophage colony-stimulating factor acts as an immunotherapy against chronic tuberculosis.
Chuang YM; He L; Pinn ML; Tsai YC; Cheng MA; Farmer E; Karakousis PC; Hung CF
Cell Mol Immunol; 2021 Oct; 18(10):2393-2401. PubMed ID: 32382128
[TBL] [Abstract][Full Text] [Related]
37. Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy.
Lin X; Huang R; Huang Y; Wang K; Li H; Bao Y; Wu C; Zhang Y; Tian X; Wang X
Int J Nanomedicine; 2021; 16():1889-1899. PubMed ID: 33707944
[TBL] [Abstract][Full Text] [Related]
38. Nanozyme Hydrogels for Self-Augmented Sonodynamic/Photothermal Combination Therapy.
Wang S; Zeng N; Zhang Q; Chen M; Huang Q
Front Oncol; 2022; 12():888855. PubMed ID: 35860592
[TBL] [Abstract][Full Text] [Related]
39. Different cytokine profiles released by CD4+ and CD8+ tumor-draining lymph node cells involved in mediating tumor regression.
Aruga A; Aruga E; Cameron MJ; Chang AE
J Leukoc Biol; 1997 Apr; 61(4):507-16. PubMed ID: 9103238
[TBL] [Abstract][Full Text] [Related]
40. Coexpression of Flt3 ligand and GM-CSF genes modulates immune responses induced by HER2/neu DNA vaccine.
Yo YT; Hsu KF; Shieh GS; Lo CW; Chang CC; Wu CL; Shiau AL
Cancer Gene Ther; 2007 Nov; 14(11):904-17. PubMed ID: 17704754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
